Anne G. Graham - Concepedia

Concepedia

Author

Anne G. Graham

Boehringer Ingelheim (United States)

Also Known As

A G Graham, A Graham, A. G. GRAHAM, A. G. Graham, A.G. Graham, Anne G. Graham

26

Publications

1.6K

Citations

10

H-Index

23

Concepts

All Affiliations

Boehringer Ingelheim (United States)Boehringer Ingelheim (Japan)

AG

About

Anne G. Graham is an author at Boehringer Ingelheim (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.5K
2	Biochemistry	6	6	1.4K
3	Natural Sciences	4	4	579
4	Allergy	1	1	34
5	Cell Biology	1	1	832

Anne G. Graham

×

9

Publications

1.6K

Citations

9

H-Index

	Year	Citations
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Christopher Pargellis, Liang Tong, Laurie Churchill, Nature Structural Biology Molecular PharmacologyDrug TargetMolecular PhysiologySignal TransductionBiochemistry	2002	832
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate John R. Regan, Steffen Breitfelder, Pier F. Cirillo, Journal of Medicinal Chemistry Drug TargetP38 Map KinaseAtp Binding SitePharmacotherapyChemical Biology	2002	349
Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-<i>tert</i>-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796) John R. Regan, Alison J. Capolino, Pier F. Cirillo, Journal of Medicinal Chemistry Drug TargetBirb 796Chemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2003	105
Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity Edward S. Lazer, Clara K. Miao, Charles L. Cywin, Journal of Medicinal Chemistry	1997	92
Selective inhibition of human cyclo-oxygenase-2 by meloxicam Laurie Churchill, Anne G. Graham, C-K. Shih, Inflammopharmacology Selective InhibitionMedicinal ChemistryBiochemistryRedox RegulatorMedicine	1996	92
The role of 5-lipoxygenase products in preclinical models of asthma Craig D. Wegner, Robert H. Gundel, William M. Abraham, Journal of Allergy and Clinical Immunology AsthmaInflammationAllergyBiochemistryMedicine	1993	34
Benzoxazolamines and Benzothiazolamines: Potent, Enantioselective Inhibitors of Leukotriene Biosynthesis with a Novel Mechanism of Action Edward S. Lazer, Clara K. Miao, Hin-Chor Wong, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyHeterocycle ChemistryPharmaceutical ChemistryMedicinal Chemistry	1994	33
Effect of structure on potency and selectivity in 2,6-disubstituted-4-(2-arylethenyl)phenol lipoxygenase inhibitors Edward S. Lazer, Hin Chor Wong, Craig D. Wegner, Journal of Medicinal Chemistry	1990	16
Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: Novel inhibitors of COX-2 Edward S. Lazer, Ronald Sorcek, Charles L. Cywin, Bioorganic & Medicinal Chemistry Letters Antiinflammatory 2-Benzyl-4-sulfonyl-4h-isoquinoline-1,3-dionesMedicinal ChemistryPharmacologyPharmacological AgentPharmacotherapy	1998	15

Page 1